Comment on ‘Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?’: Type I interferons as possible link between COVID‐19 vaccine and vitiligo
“…In particular, given that vaccination against Covid‐19 promotes the production of type 1 interferons (IFN‐I) by stimulating the recruitment of plasmacytoid dendritic cells, 13 it has been proposed that vaccine‐induced IFN‐I production may serve as a trigger to vitiligo in genetically predisposed individuals. 14 Remarkably, the onset of multiple halo nevi has been reported in a 22‐year‐old female with multiple sclerosis treated with IFNβ‐1a a few weeks after therapy was started. 15 …”
Halo nevi, also known as Sutton nevi, are characterized by the development of a rim of depigmentation around a nevus. These nevi usually occur in healthy children or young adults as single lesions and are considered benign entities, whereas in adults, the sudden appear-
“…About vitiligo, Abdullah et al hypothesized that the link between SARS‐CoV‐2 vaccination and vitiligo may be the type 1 interferon (IFN‐1) produced by dendritic plasmacytoid cells (pDC). 9 …”
mentioning
confidence: 99%
“…8 About vitiligo, Abdullah et al hypothesized that the link between SARS-CoV-2 vaccination and vitiligo may be the type 1 interferon (IFN-1) produced by dendritic plasmacytoid cells (pDC). 9 The activation of pDCs, in fact, induces a high production of IFN-1. The activation of such cells can be induced by viral nucleic acid sequences through toll-like receptors (TLRs) 7 and 9.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.